Table of Contents

September 1, 2024; Volume 65,Issue 9

  1. Abdelhafez, Yasser G.

    1. Total-Body Dynamic Imaging and Kinetic Modeling of [<sup>18</sup>F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy
      Open Access
      Total-Body Dynamic Imaging and Kinetic Modeling of [18F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy
      Negar Omidvari, Jelena Levi, Yasser G. Abdelhafez, Yiran Wang, Lorenzo Nardo, Megan E. Daly, Guobao Wang and Simon R. Cherry
      Journal of Nuclear Medicine September 1, 2024, 65 (9) 1481-1488; DOI: https://doi.org/10.2967/jnumed.123.267003

  2. Abdelrazek, Ahmad S.

    1. Neurologic Symptoms After <sup>177</sup>Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
      Neurologic Symptoms After 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
      Gokce Belge Bilgin, Brian J. Burkett, Cem Bilgin, Jacob J. Orme, Daniel S. Childs, Miguel Muniz Rincon, Ahmad S. Abdelrazek, Derek R. Johnson, Geoffrey B. Johnson, Eugene D. Kwon, Oliver Sartor and Ayse Tuba Kendi
      Journal of Nuclear Medicine September 1, 2024, 65 (9) 1402-1408; DOI: https://doi.org/10.2967/jnumed.124.267643

  3. Abdlkadir, Ahmed

    1. [177Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy: Initial Clinical Experience in Renal Carcinoid
      Akram Al-Ibraheem, Ahmed Abdlkadir, Dhuha Al-Adhami and Ken Herrmann
      Journal of Nuclear Medicine September 1, 2024, 65 (9) 1494; DOI: https://doi.org/10.2967/jnumed.124.267497

  4. Afchain, Pauline

    1. Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network
      Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network
      Aurelien Fosse, Julien Hadoux, Paul Girot, Amandine Beron, Pauline Afchain, Anne-Segolene Cottereau, Eric Baudin, Lawrence O. Dierickx, Thierry Lecomte, Marine Perrier, Come Lepage, Karine Bouhier-Leporrier, Bernard Goichot, Boumediene Lachachi, Thomas Walter and Alice Durand
      Journal of Nuclear Medicine September 1, 2024, 65 (9) 1416-1422; DOI: https://doi.org/10.2967/jnumed.123.267363

  5. Aggarwal, Rahul R.

    1. Impact of Posttreatment SPECT/CT on Patient Management During <sup>177</sup>Lu-PSMA-617 Radiopharmaceutical Therapy
      Impact of Posttreatment SPECT/CT on Patient Management During 177Lu-PSMA-617 Radiopharmaceutical Therapy
      Surekha Yadav, Blair Lowery, Abuzar Moradi Tuchayi, Fei Jiang, Rachelle Saelee, Rahul R. Aggarwal, Roxanna Juarez, Robert R. Flavell and Thomas A. Hope
      Journal of Nuclear Medicine September 1, 2024, 65 (9) 1395-1401; DOI: https://doi.org/10.2967/jnumed.124.267955

  6. Agrawal, Shikha

    1. Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CT
      Utility of 64Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on 68Ga-PSMA-11 PET/CT
      Sherrington Li, Andrew Nguyen, William Counter, Nikeith C. John, Jeremiah De Leon, George Hruby, Anthony M. Joshua, Phillip Stricker, Megan Crumbaker, Narjess Ayati, Lyn Chan, Zahra Sabahi, Mina Swiha, Andrew Kneebone, Keith Wong, Victor Liu, Shikha Sharma, Shikha Agrawal and Louise M. Emmett
      Journal of Nuclear Medicine September 1, 2024, 65 (9) 1371-1375; DOI: https://doi.org/10.2967/jnumed.124.267881

  7. Ah-thiane, Loic

    1. Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions
      Loic Ah-Thiane, Ludovic Ferrer, Stéphane Supiot and Caroline Rousseau
      Journal of Nuclear Medicine September 1, 2024, 65 (9) 1496-1497; DOI: https://doi.org/10.2967/jnumed.124.267477

  8. Al-adhami, Dhuha

    1. [177Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy: Initial Clinical Experience in Renal Carcinoid
      Akram Al-Ibraheem, Ahmed Abdlkadir, Dhuha Al-Adhami and Ken Herrmann
      Journal of Nuclear Medicine September 1, 2024, 65 (9) 1494; DOI: https://doi.org/10.2967/jnumed.124.267497

  9. Al-ibraheem, Akram

    1. [177Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy: Initial Clinical Experience in Renal Carcinoid
      Akram Al-Ibraheem, Ahmed Abdlkadir, Dhuha Al-Adhami and Ken Herrmann
      Journal of Nuclear Medicine September 1, 2024, 65 (9) 1494; DOI: https://doi.org/10.2967/jnumed.124.267497

  10. Al-naqeeb, Ghadah

    1. Paraplegic Patient with Metastatic Papillary Thyroid Cancer: A Multidisciplinary Approach to Radioactive Iodine Therapy Safety and Efficacy Strategy
      Ghadah Al-Naqeeb, Eric Munger, Amrita L. Ramanathan, Andrew Makarewicz, Noha Behairy, Padmasree Veraraghavan, Craig Cochran, Philip Bernaldez, Iman Clinton, Newbegin Devaraj, Korressa Lee, Teresa Fisher, Olumide Owoade, Roberto Maass-Moreno, Babak Saboury, Sriram Gubbi and Joanna Klubo-Gwiezdzinska
      Journal of Nuclear Medicine September 1, 2024, 65 (9) 1336-1339; DOI: https://doi.org/10.2967/jnumed.123.266955
« Previous (Pages : 1 2 3 4 5 6 ... 31) Next »
Back to top

In this issue